Single- and multiple-dose pharmacokinetics of bosentan and its interaction with ketoconazole-Reference-Cited by-同舟云学术

Single- and multiple-dose pharmacokinetics of bosentan and its interaction with ketoconazole

Published:2002-06 Issue:6 Volume:53 Page:589-595
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

van Giersbergen Paul L. M.,Halabi Atef,Dingemanse Jasper

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.2002.01608.x/fullpdf

Reference25 articles.

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells;Yanagisawa;Nature,1988

2. The endothelin family of peptides: local hormones with diverse roles in health and disease?;Haynes;Clin Sci,1993

3. Endothelin. New discoveries and rapid progress in clinic;Webb;Trends Pharmacol Sci,1998

4. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist;Clozel;J Pharmacol Exp Ther,1994

5. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study;Channick;Lancet,2001

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfabricated potentiometric sensor based on a carbon nanotube transducer layer for selective Bosentan determination;Reviews in Analytical Chemistry;2024-01-01

2. Current and future strategies for targeting the endothelin pathway in cardiovascular disease;Nature Cardiovascular Research;2023-11-02

3. Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives;Pharmacogenomics and Personalized Medicine;2023-07

4. Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients;Acta Pharmaceutica Sinica B;2023-01

5. Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for in vitro Human Cytochrome P450 Enzyme Induction;Frontiers in Toxicology;2022-06-20